- Home
- AIRE vs AEON Comparison
AIRE vs AEON Comparison
Compare AIRE & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRE | AEON |
|---|---|---|
| Founded | 2021 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 13.0M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIRE | AEON |
|---|---|---|
| Price | $1.34 | $0.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $1.78 |
| AVG Volume (30 Days) | 30.9K | ★ 7.1M |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,518,498.00 | N/A |
| Revenue This Year | $196.12 | N/A |
| Revenue Next Year | $79.50 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 376.42 | N/A |
| 52 Week Low | $0.16 | $0.18 |
| 52 Week High | $3.98 | $1.45 |
Technical Indicators
Market Signals| Indicator | AIRE | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 57.65 |
| Support Level | $1.29 | $0.23 |
| Resistance Level | $1.62 | $0.33 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 10.34 | 60.32 |
Price Performance
Historical ComparisonAbout AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.